Covid Patients Taking Antidepressant May Have Lower Death Risk

Nov. 15, 2021, 4:00 PM

A common antidepressant appears to reduce the risk of death in patients admitted to the hospital with severe Covid-19, according to a study published in the JAMA Network Open journal.

About 9.8% of the 470 Covid-19 patients in the study who were taking fluoxetine, also sold under the brand name Prozac, died. That’s compared to over 13% of patients with similar characteristics not receiving any antidepressants.

A recent trial in Brazil showed fluvoxamine, another antidepressant, may reduce the risk that a patient with Covid-19 ends up in the hospital. The antidepressant was chosen to be studied as a potential treatment ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.